Go Ad-Free
    My Alerts
    VICTORIS
    Budget Express 2026

    co-presented by

    • LIC
    • JIO BlackRock

    ASSOCIATE SPONSORS

    • Sunteck
    • SBI
    • Emirates
    • Dezerv
    Loans
    Loans
    HomeNewsBusinessAnnouncementsAurobindo Pharma receives final approvals for Montelukast Sodium Tablets and Chewable Tablets

    Aurobindo Pharma receives final approvals for Montelukast Sodium Tablets and Chewable Tablets

    Aurobindo Pharma receives final approvals for Montelukast Sodium Tablets and Chewable Tablets

    August 06, 2012 / 11:37 IST

    Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Montelukast Sodium Tablets 10mg (ANDA 202468) and Montelukast Sodium Chewable Tablets 4mg and 5mg (ANDA202096). The products are ready for a first-day launch.

    Montelukast Sodium Tablets 10mg and Chewable Tablets 4mg and 5mg are the generic equivalent of Merck & Co. Inc

    first published: Aug 6, 2012 11:37 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347